RNA polymerase II degradation in response to rapamycin is not mediated through ubiquitylation

Biochemical and Biophysical Research Communications

Volumn 413, Issue 2, 2011, Pages 248-253

  Jouvet, Nathalie ^a   Poschmann, Jeremie ^a,b   Douville, Julie ^a   Marrakchi, Rim ^a   Ramotar, Dindial ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Peptidyl prolyl isomerase; Rapamycin; RNA polymerase II degradation; Rrd1; Ubiquitylation

Indexed keywords

ELONGIN C; PEPTIDYLPROLYL ISOMERASE; RAPAMYCIN; RESISTANT TO RAPAMYCIN DELETION 1; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FUNGAL STRAIN; ISOMERIZATION; NONHUMAN; PRIORITY JOURNAL; RNA DEGRADATION; RNA TRANSCRIPTION; SACCHAROMYCES CEREVISIAE; STRESS; UBIQUITINATION;

IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDYLPROLYL ISOMERASE; RNA POLYMERASE II; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIROLIMUS; UBIQUITINATION;

SACCHAROMYCES CEREVISIAE;

EID: 80053099763     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.079     Document Type: Article

References (35)

1. Saylor P.J., Michaelson M.D. New treatments for renal cell carcinoma: targeted therapies. J. Natl. Compr. Canc. Netw. 2009, 7:645-656.
2. Bjornsti M.A., Houghton P.J. The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer 2004, 4:335-348.
3. Hardwick J.S., Kuruvilla F.G., Tong J.K., et al. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc. Natl. Acad. Sci. USA 1999, 96:14866-14870.
4. Heitman J., Movva N.R., Hall M.N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 1991, 253:905-909.
5. Crespo J.L., Hall M.N. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 2002, 66:579-591. (table of contents).
6. Douville J., David J., Lemieux K.M., et al. The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure. Genetics 2006, 172:1369-1372.
7. Poschmann Jeremie, Drouin Simon, Jacques Pierre-Etienne, Fadili Karima El, Newmarch Michael, Robert François, Ramotar Dindial The peptidyl prolyl isomerase Rrd1 regulates the elongation of RNA Polymerase II during transcriptional stresses. PLoS ONE 2011, 10.1371/journal.pone.0023159.
8. Jouvet N., Poschmann J., Douville J., et al. Rrd1 isomerizes RNA polymerase II in response to rapamycin. BMC Mol. Biol. 2010, 11:92.
9. Fournier M.L., Paulson A., Pavelka N., et al. Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin. Mol. Cell. Proteomics 2010, 9:271-284.
10. Cardenas M.E., Cutler N.S., Lorenz M.C., et al. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 1999, 13:3271-3279.
11. Jung Y., Lippard S.J. RNA polymerase II blockage by cisplatin-damaged DNA. Stability and polyubiquitylation of stalled polymerase. J. Biol. Chem. 2006, 281:1361-1370.
12. Inukai N., Yamaguchi Y., Kuraoka I., et al. A novel hydrogen peroxide-induced phosphorylation and ubiquitination pathway leading to RNA polymerase II proteolysis. J. Biol. Chem. 2004, 279:8190-8195.
13. Malik S., Bagla S., Chaurasia P., et al. Elongating RNA polymerase II is disassembled through specific degradation of its largest but not other subunits in response to DNA damage in vivo. J. Biol. Chem. 2008, 283:6897-6905.
14. Ribar B., Prakash L., Prakash S. ELA1 and CUL3 are required along with ELC1 for RNA polymerase II polyubiquitylation and degradation in DNA-damaged yeast cells. Mol. Cell Biol. 2007, 27:3211-3216.
15. Ribar B., Prakash L., Prakash S. Requirement of ELC1 for RNA polymerase II polyubiquitylation and degradation in response to DNA damage in Saccharomyces cerevisiae. Mol. Cell Biol. 2006, 26:3999-4005.
16. Selth L.A., Sigurdsson S., Svejstrup J.Q. Transcript elongation by RNA polymerase II. Annu. Rev. Biochem. 2010, 79:271-293.
17. Somesh B.P., Sigurdsson S., Saeki H., Erdjument-Bromage H., Tempst P., Svejstrup J.Q. Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD. Cell 2007, 129:57-68.
18. Svejstrup J.Q. Contending with transcriptional arrest during RNAPII transcript elongation. Trends Biochem. Sci. 2007, 32:165-171.
19. Wysocki R., Fortier P.K., Maciaszczyk E., et al. Transcriptional activation of metalloid tolerance genes in Saccharomyces cerevisiae requires the AP-1-like proteins Yap1p and Yap8p. Mol. Biol. Cell 2004, 15:2049-2060.
20. Somesh B.P., Reid J., Liu W.F., et al. Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest. Cell 2005, 121:913-923.
21. Vongsamphanh R., Fortier P.K., Ramotar D. Pir1p mediates translocation of the yeast Apn1p endonuclease into the mitochondria to maintain genomic stability. Mol. Cell Biol. 2001, 21:1647-1655.
22. Douville J., David J., Fortier P.K., et al. The yeast phosphotyrosyl phosphatase activator protein, yPtpa1/Rrd1, interacts with Sit4 phosphatase to mediate resistance to 4-nitroquinoline-1-oxide and UVA. Curr. Genet. 2004, 46:72-81.
23. Svejstrup J.Q., Petrakis T.G., Fellows J. Purification of elongating RNA polymerase II and other factors from yeast chromatin. Methods Enzymol. 2003, 371:491-498.
24. Beaudenon S.L., Huacani M.R., Wang G., et al. Rsp5 ubiquitin-protein ligase mediates DNA damage-induced degradation of the large subunit of RNA polymerase II in Saccharomyces cerevisiae. Mol. Cell Biol. 1999, 19:6972-6979.
25. Jeong S.J., Kim H.J., Yang Y.J., et al. Role of RNA polymerase II carboxy terminal domain phosphorylation in DNA damage response. J. Microbiol. 2005, 43:516-522.
26. Phatnani H.P., Greenleaf A.L. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 2006, 20:2922-2936.
27. Jones J.C., Phatnani H.P., Haystead T.A., et al. C-terminal repeat domain kinase I phosphorylates Ser2 and Ser5 of RNA polymerase II C-terminal domain repeats. J. Biol. Chem. 2004, 279:24957-24964.
28. Kristjuhan A., Walker J., Suka N., et al. Transcriptional inhibition of genes with severe histone h3 hypoacetylation in the coding region. Mol. Cell 2002, 10:925-933.
29. Lorenz M.C., Heitman J. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 1995, 270:27531-27537.
30. Jordens J., Janssens V., Longin S., et al. The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase. J. Biol. Chem. 2006, 281:6349-6357.
31. Leulliot N., Vicentini G., Jordens J., et al. Crystal structure of the PP2A phosphatase activator: implications for its PP2A-specific PPIase activity. Mol. Cell 2006, 23:413-424.
32. Chao Y., Xing Y., Chen Y., et al. Structure and mechanism of the phosphotyrosyl phosphatase activator. Mol. Cell 2006, 23:535-546.
33. Ratner J.N., Balasubramanian B., Corden J., et al. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair. J. Biol. Chem. 1998, 273:5184-5189.
34. Dyavaiah M., Rooney J.P., Chittur S.V., et al. Autophagy-dependent regulation of the DNA damage response protein ribonucleotide reductase 1. Mol. Cancer Res. 2011, 9:462-475.
35. Robert T., Vanoli F., Chiolo I., et al. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 2011, 471:74-79.